These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17048260)

  • 1. Role of drug efflux carriers in the healthy and diseased brain.
    Hermann DM; Kilic E; Spudich A; Krämer SD; Wunderli-Allenspach H; Bassetti CL
    Ann Neurol; 2006 Nov; 60(5):489-498. PubMed ID: 17048260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of multidrug resistance transporters at the blood-brain barriers.
    Scherrmann JM
    Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):233-46. PubMed ID: 16922639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.
    Bakhsheshian J; Wei BR; Chang KE; Shukla S; Ambudkar SV; Simpson RM; Gottesman MM; Hall MD
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20801-6. PubMed ID: 24297888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of ATP-binding cassette transporters for brain pharmacotherapies.
    Hermann DM; Bassetti CL
    Trends Pharmacol Sci; 2007 Mar; 28(3):128-34. PubMed ID: 17275929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bringing drugs into the injured brain and keeping them there.
    Hermann DM; Patak P
    Curr Pharm Des; 2011; 17(26):2748-9. PubMed ID: 21827401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration.
    Vautier S; Milane A; Fernandez C; Chacun H; Lacomblez L; Farinotti R
    J Pharm Pharm Sci; 2009; 12(2):199-208. PubMed ID: 19732497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration.
    Tang SC; Lagas JS; Lankheet NA; Poller B; Hillebrand MJ; Rosing H; Beijnen JH; Schinkel AH
    Int J Cancer; 2012 Jan; 130(1):223-33. PubMed ID: 21351087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of ATP-binding cassette transporters in the diseased brain: Context matters.
    Baltira C; Aronica E; Elmquist WF; Langer O; Löscher W; Sarkaria JN; Wesseling P; de Gooijer MC; van Tellingen O
    Cell Rep Med; 2024 Jun; 5(6):101609. PubMed ID: 38897176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual mTORC1 and mTORC2 inhibitor Palomid 529 penetrates the blood-brain barrier without restriction by ABCB1 and ABCG2.
    Lin F; Buil L; Sherris D; Beijnen JH; van Tellingen O
    Int J Cancer; 2013 Sep; 133(5):1222-33. PubMed ID: 23436212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
    Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
    Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier.
    Bihorel S; Camenisch G; Lemaire M; Scherrmann JM
    J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-administration strategy to enhance brain accumulation of vandetanib by modulating P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp1/Abcg2) mediated efflux with m-TOR inhibitors.
    Minocha M; Khurana V; Qin B; Pal D; Mitra AK
    Int J Pharm; 2012 Sep; 434(1-2):306-14. PubMed ID: 22633931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells.
    ElAli A; Hermann DM
    Brain Pathol; 2012 Mar; 22(2):175-87. PubMed ID: 21767321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
    Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
    Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
    Sharom FJ
    Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
    Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
    Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the multikinase inhibitors sorafenib and sunitinib with solute carriers and ATP-binding cassette transporters.
    Hu S; Chen Z; Franke R; Orwick S; Zhao M; Rudek MA; Sparreboom A; Baker SD
    Clin Cancer Res; 2009 Oct; 15(19):6062-9. PubMed ID: 19773380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Progress on the Role of ABC Transporters in the Drug Resistance Mechanism of Intractable Epilepsy.
    Xiong J; Mao DA; Liu LQ
    Biomed Res Int; 2015; 2015():194541. PubMed ID: 26491660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunction of ABC transporters at the blood-brain barrier: Role in neurological disorders.
    Gil-Martins E; Barbosa DJ; Silva V; Remião F; Silva R
    Pharmacol Ther; 2020 Sep; 213():107554. PubMed ID: 32320731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.